The point was the profit margin on both the blindness drug and AMD CPUs are significantly higher than for ozempic. So why target ozempic for too high a profit

The point was the profit margin on both the blindness drug and AMD CPUs are significantly higher than for ozempic. So why target ozempic for too high a profit margin? Caveated with its the health insurance industry is paying that profit margin - not the people who _should_ be taking it.